PharmEco Group of Companies

Search

RU | EN

BioJet – EN
  • About
    • General information
    • Administration
    • Pharmacovigilance
    • Business ethics
  • Production
  • Our products
  • News
  • Contacts

Mishustin: 90% of Essential Medicines Should Be Produced in Russia

According to the Prime Minister, this goal will be pursued as part of the national project “New Health Preservation Technologies.”

The share of domestically produced medicines from the list of essential and vital drugs (EVDL) in Russia should increase to 90% by 2030, Russian Prime Minister Mikhail Mishustin announced.

He noted that this effort will be conducted within the framework of the national project “New Health Preservation Technologies.”

“Activities under the national project ‘New Health Preservation Technologies’ will help expand the use of biomedical technologies, regenerative medicine methods, and improve access for citizens to advanced approaches in prevention and treatment. The share of domestically produced essential and vital medicines should increase to 90%,” said the Prime Minister while addressing the National Projects Council.

In April, during a report on the government’s work in 2023, Mishustin stated that the current share of domestically produced medicines from the EVDL list stands at 80%.

Source: TASS, December 5, 2024

Current news

  • June 5, 2025

    “Geropharm” receives another compulsory license for semaglutide

    The Russian government has granted Geropharm permission to use, without the patent holder’s consent, a…

  • June 5, 2025

    Bill on penalties for “medication intoxication” while driving passes first reading

    On Tuesday, the State Duma passed in the first reading a government-sponsored bill introducing administrative…

  • June 5, 2025

    FAS to investigate Russian pharmaceutical market over rising drug prices

    The Federal Antimonopoly Service (FAS) of Russia plans to investigate several domestic pharmaceutical companies due…

  • June 5, 2025

    Russia develops compounds capable of significantly suppressing tumor cell growth

    The discovery could greatly reduce chemotherapy toxicity and change future approaches to cancer treatment. Scientists…

  • June 5, 2025

    “Genealogical Extract”: Pharmaceutical Industry Discusses Mechanisms for Defining Manufacturing Nationality

    At the Semashko Russian Pharmaceutical Forum, domestic and international pharmaceutical companies gathered to discuss fair…

LLC “BioJet”. all rights reserved

  • Legal information